DON'T CLOUD THE SUN-SAFE MESSAGE
8 December 2018
Mark Whittaker’s ‘Here comes the sun; Defending our summer rays’ (GW 24 Nov) clouds the sun-safe message – which could have disastrous consequences. The scientific evidence is clear and undisputable that UV exposure and the damage it causes is the single greatest risk factor for developing melanoma. UV radiation damages skin cells and causes mutations in DNA. And melanoma kills. It is the most common cancer affecting 15 to 39 year old Australians, and kills one Australian every five hours.
Sunshine isn’t the culprit here, but excess sunshine is. We enjoy our iconic Aussie outdoor lifestyle as much as the next person. But with one of the highest melanoma rates in the world, all Australians, including Good Weekend writers and editors, have a responsibility to advocate for enjoying sunshine safely. Living a sun-safe life is as simple as wearing a broad-brimmed hat, using 50+ sunscreen, covering up with long pants, sleeves and sunglasses, and seeking shade in the hottest part of the day.
By alluding to the many possible therapeutic benefits of sunshine while at the same time questioning whether his sunscreen use is ‘doing any good’, Mark Whittaker is doing all Australians a disservice. His reference to a small 1998 German study about possible therapeutic benefits of tanning beds is also dangerous. How many of those 18 participants went on to develop melanoma from their sunbed use? Melanoma Institute Australia led the campaign to have commercial sunbeds banned across the country due to their high melanoma risk, with many states in the USA following suit andthe UK now lobbying for a similar ban.
Mark also uses the anomaly of why some people develop melanoma but others don’t, to question how sun exposure can be to blame. The answer lies in genetics – and not in undermining the dangerous impact of UV exposure. Our researchers have discovered many of the hereditary genes that explain why some people get melanoma and others do not. A simple glance at the DNA of skin melanomas shows that nearly all have been caused by sun damage.
Sunshine may well have many therapeutic benefits, but questioning long-held and scientifically proven evidence about sunscreen and the link between UV exposure and melanoma is dangerous. And the cusp of summer, when UV levels are at their highest and most damaging, is not the time to be playing Devil’s Advocate.
While we at Melanoma Institute Australia are investing in research and trialling new melanoma treatments, as well as educating the community about the need to protect themselves from the sun, it is frustrating and disheartening to see Good Weekend clouding the issue about sun exposure and potentially undermining our efforts to save lives.
Just as we will continue to fight to save the lives of melanoma patients, many in their teens, 20s and 30s, we will continue to espouse the danger of excessive sun exposure and advocate for living a sun-safe life.
And Mark, please use that Sun Smart app. It just may save your life.
Professor Georgina Long and Professor Richard Scolyer
Melanoma Institute Australia
For more information, please contact:
Jennifer Durante |Melanoma Institute Australia | 0412 798 990 |firstname.lastname@example.org
Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.
Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.
It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA, so we can continue to edge closer to our goal of zero deaths from melanoma.
They are a formidable team - in work and in play
This week, Melanoma Institute Australia hosted the first of six
Federal government urged
We want to thank every member of Team Melanoma and everyone who donated to them. With your help, we are moving closer to our goal of zero deaths from melanoma!
Lauren O'Brien tells us why she's running for a cause close to her heart
MIA could not do what we do without the incredible support and effort of our community fundraisers. We’d like to highlight some of the wonderful events organised by our community in
An international study, led by researchers from Melanoma Institute Australia, QIMR Berghofer Medical Research Institute and The University of Sydney as part of the Australian Melanoma Genome Project, has discovered that a drug traditionally used to treat a
Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
“I’m the age Emma was when she passed away. It almost feels
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.
MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.
Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.
Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.
Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.